$1.36
0.086.25%
At close: -
$1.38
0.021.46%
After Hours: Dec 20, 7:58 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for NeuroSense Therapeutics in recent months.
Browse guidance and forecast on all stocks.